HIIFS
ELOX

Harel Insurance Investments & Financial Services’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-29,410
Closed -$74K – 815
2023
Q1 		$74K Hold
29,410
– – ﹤0.01% 443
2022
Q4 		$54K Hold
29,410
– – ﹤0.01% 466
2022
Q3 		$200K Hold
29,410
– – ﹤0.01% 295
2022
Q2 		$318K Hold
29,410
– – 0.01% 291
2022
Q1 		$659K Hold
29,410
– – 0.01% 230
2021
Q4 		$831K Buy
+29,410
New +$1.28M 0.02% 187

Other funds holding ELOX

SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Harel Insurance Investments & Financial Services's ELOX Position: Q2 2023 in Review

Harel Insurance Investments & Financial Services sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q2 2023, closing a stake of 29,410 shares — an estimated $74K sold.

Harel Insurance Investments & Financial Services first reported a position in ELOX in Q4 2021 and held it in 6 quarters. The position peaked at $831K in Q4 2021. 16 funds tracked by Wall St. Rank hold ELOX as of Q2 2023.

  • Harel Insurance Investments & Financial Services reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 29,410 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $74K.
  • Harel Insurance Investments & Financial Services first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
  • Harel Insurance Investments & Financial Services's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $831K in Q4 2021.
  • 16 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q2 2023.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2023, filed 17 Jul 2023.